Cinclus Pharma at Redeye Investor Forum Online, September 19th
Christer Ahlberg, CEO of Cinclus Pharma, will present the company's latest updates and the development of linaprazan glurate at Redeye Investor Forum Online on September 19th.
Read more
News
Check out the latest news from Cinclus Pharma
Watch the presentation from Aktiespararnas event September 17th
Here you can watch the full presentation (in Swedish) of Cinclus Pharma and the development of the drug candidate linaprazan glurate, held by CEO Christer Ahlberg at Aktiespararnas event September 17th.
Read more
Cinclus Pharma participates in Aktiespararnas event on September 17th
On September 17th, Christer Ahlberg, CEO of Cinclus Pharma, will present the company and the development of the drug candidate linaprazan glurate at Aktiespararnas event Stora Aktiedagarna.
Read more